Biopharmaceutical provider opens dedicated facility in Germany

SGS a global biopharmaceutical analytical and bioanalytical contract solutions provider, has opened a new facility in Wiesbaden, Germany,  to offer extractables and leachables testing to the pharmaceutical and related industries. SGS had previously offered these services from its Taunusstein, Germany laboratory but customer demand has seen the need for a dedicated facility and increased investment for this business.

 “This investment in both a new facility and advanced analytical technologies is in response to increased awareness of regulatory requirements globally and growing customer demand,” commented Dr. Sheida Hoenlinger, director, life sciences Germany.

“SGS has a very strong reputation within the industry for extractables and leachables testing, and this step, to build a dedicated facility, allows us to offer our clients greater opportunities to identify the unknowns through more sensitive and accurate impurity profiling techniques.”

The new facility in Wiesbaden will be the global Center of Excellence for Extractable Studies and Impurities Profiling, as a hub across the global network of laboratories.